The Biology and Interplay of Immunotherapy by Leukemia-Oncolytic Virus (iLOV) Immune Responses
Oncolytic viruses (OVs) are novel biological agents that selectively infect and kill malignant cells. OVs can also generate anti-cancer immunity. Our lab exploited this phenomenon and developed an in vitro vaccine with infected leukemia cells with oncolytic virus vaccine – and named immunotherapy by...
Main Author: | Tsang, Jovian |
---|---|
Other Authors: | Bell, John |
Language: | en |
Published: |
Université d'Ottawa / University of Ottawa
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/31873 http://dx.doi.org/10.20381/ruor-6770 |
Similar Items
-
Characterization of the Anti-Tumour Immune Response Following Treatment with an Infected Leukemia Cell Vaccine
by: Dempster, Holly
Published: (2018) -
Perspectives on immunotherapy via oncolytic viruses
by: Alberto Reale, et al.
Published: (2019-02-01) -
Oncolytic viruses for cancer immunotherapy
by: Otto Hemminki, et al.
Published: (2020-06-01) -
Targeting Autophagy for Oncolytic Immunotherapy
by: Lulu Hu, et al.
Published: (2017-01-01) -
Targeting Tumour Vasculature with Oncolytic Viruses
by: De Silva, Naomi Samantha
Published: (2014)